REGN
$REGN
Regeneron Pharmaceuticals
Biotech company known for Eylea and Dupixent immunology drugs.
Healthcare$654.27
+29.55 (+4.73%)
Day Range$625.70 - $654.93
Prev Close$624.72
Analyst Rating
Strong Buy
27 Buy / 11 Hold / 0 Sell
Subscribers
1
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
REGN: EYLEA Update and Earnings Momentum (REGN)
Regeneron (REGN) benefits from FDA label expansion for extended EYLEA HD dosing and a strong analyst consensus. Upcoming Q1 results and tariff headlines create near-term volatility but the longer-term growth outlook remains constructive.
Apr 6, 2026